CONTENTS 
Human Gene Transfer Protocol 9306-049, Gary J. Nabel 1 
Human Gene Transfer Protocol 9306-050, Corey Raffel and Kenneth Culver 49 
Human Gene Transfer Protocol 9306-051, Charles Hesdorffer and Karen Antman . . 90 
Human Gene Transfer Protocol 9306-052, Joseph Ilan 127 
The Poxvirus Vectors NYVAC, ALVAC and TROVAC-Reduction of Physical 
Containment from BL2 to BL1, Enzo Paoletti 156 
Federal Register of August 18, 1993, Announcing a Meeting and Proposed Actions of 
the Recombinant DNA Advisory Committee Meeting, September 9-10, 1993 175 
Minutes of the Recombinant DNA Advisory Committee Meeting, September 9-10, 
1993 179 
Human Gene Transfer Protocol 9309-053, Peter Cassileth et al 240 
Human Gene Transfer Protocol 9309-054, Joyce O’Shaughnessy 271 
Human Gene Transfer Protocol 9309-055, Larry E. Kun et al 301 
Human Gene Transfer Protocol 9309-056, Tapas K. Das Gupta and Edward P. 
Cohen 341 
Human Gene Transfer Protocol 9309-057, Flossie Wong-Staal et al 377 
Human Gene Transfer Protocol 9309-058, James S. Economou and John A. Glasby 411 
Semliki Forest Virus (SFV) Vector Expression System-Reduction in Physical 
Containment from BL3 to BL2, Gary F. Temple 443 
Federal Register of September 13, 1993, Promulgating Actions Under the NIH Guidelines 
Involving Additions to Appendix D-XLVI, D-XLVII, D-XLVIII, D-XLIX, D-L, D-LI, D- 
LII, D-LIII, D-LIV, D-LV, D-LVI and Amendments to Section IV-C-3-c and Section III- 
A-4 of the NIH Guidelines 490 
Federal Register of October 18, 1993, Promulgating Actions Under the NIH Guidelines 
Involving Amendment to Appendix D-XXVII, Additions to Appendix D-LVII, D-LVIII, 
D-LIX, D-LX, Amendment to Section III of the NIH Guidelines, Amendment to the 
Points to Consider, and Amendments to Sections III, IV, V and Appendix C and F of the 
NIH Guidelines 497 
Recombinant DNA Research, Volume 18 
[v] 
